APA (7th ed.) Citation

Boundy, E. O., Fast, H., Jatlaoui, T. C., Razzaghi, H., Harris, L., Nguyen, K., . . . Black, C. L. (2025). Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination -- United States, October 2023-March 2024. MMWR: Morbidity & Mortality Weekly Report, 74(31), 484. https://doi.org/10.15585/mmwr.mm7431a3

Chicago Style (17th ed.) Citation

Boundy, Ellen O., Hannah Fast, Tara C. Jatlaoui, Hilda Razzaghi, LaTreace Harris, Kimberly Nguyen, Jamie Mells, Georgina Peacock, and Carla L. Black. "Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination -- United States, October 2023-March 2024." MMWR: Morbidity & Mortality Weekly Report 74, no. 31 (2025): 484. https://doi.org/10.15585/mmwr.mm7431a3.

MLA (9th ed.) Citation

Boundy, Ellen O., et al. "Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination -- United States, October 2023-March 2024." MMWR: Morbidity & Mortality Weekly Report, vol. 74, no. 31, 2025, p. 484, https://doi.org/10.15585/mmwr.mm7431a3.